UCSF has opened an automated hospital pharmacy believed to be the nation’s most comprehensive facility using robotic technology and electronics to prepare and track medications with the goal of improving patient safety.
March 07, 2011
February 28, 2011
UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.
February 03, 2011
UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
December 15, 2010
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
December 13, 2010
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
December 02, 2010
UCSF Chancellor Sue Desmond-Hellmann named campus leader Renee Navarro, past director of academic diversity, as the University’s first vice chancellor of diversity and outreach.
November 10, 2010
Paul Ortiz de Montellano has been appointed associate dean of research in the UCSF School of Pharmacy, a key advisor to the dean on campus, national and international science opportunities issues and trends.
November 01, 2010
Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College London.
November 01, 2010
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
October 22, 2010
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.